Related Experiment Video

Updated: Jul 16, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Interaction of Duffy antigen receptor for chemokines and KAI1: a critical step in metastasis suppression

Megumi Iiizumi1, Sucharita Bandyopadhyay, Kounosuke Watabe

  • 1Department of Medical Microbiology and Immunology, Southern Illinois University School of Medicine, 801 North Rutledge Street, Springfield, IL 62794, USA.

Cancer Research
|February 20, 2007
PubMed

Insights

The KAI1/CD82 protein suppresses tumor metastasis by interacting with the Duffy antigen receptor for chemokines (DARC), inducing cancer cell senescence. This discovery offers a novel therapeutic target for preventing cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Tumor metastasis suppressor protein KAI1/CD82 is downregulated in many human cancers.
  • The precise molecular mechanism underlying KAI1's metastasis suppressor function is not fully understood.
  • KAI1/CD82 plays a crucial role in regulating cancer cell dissemination and secondary tumor formation.

Purpose of the Study:

  • To elucidate the molecular mechanism by which KAI1/CD82 suppresses tumor metastasis.
  • To investigate the interaction between KAI1 and other cellular proteins in the context of metastasis.
  • To identify potential therapeutic targets for inhibiting cancer metastasis.

Main Methods:

  • In vitro and in vivo experimental models were utilized.
  • The interaction between KAI1/CD82 and the Duffy antigen receptor for chemokines (DARC) was examined.
  • Cellular signaling pathways, including senescence induction, were analyzed.

Main Results:

  • KAI1/CD82 interacts with DARC on the surface of endothelial cells.
  • This KAI1-DARC interaction transmits a senescence signal to cancer cells expressing KAI1.
  • Loss of KAI1 expression allows cancer cells to proliferate, facilitating metastasis.

Conclusions:

  • KAI1/CD82 suppresses metastasis by interacting with DARC, inducing cancer cell senescence.
  • Metastasis suppression is dependent on host tissue interactions mediated by KAI1.
  • The KAI1-DARC interaction represents a promising therapeutic target for anti-metastasis cancer therapies.

More Related Videos

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...